Respiratory inhaler devices are essential tools for delivering medication directly into the lungs for the treatment and management of respiratory conditions such as asthma, chronic obstructive ...

Key drivers include developments in smart and sustainable designs. The respiratory inhaler devices market is expected to ...

Regarding who can use these inhalers, NHS guidelines state: "Most adults can use beclometasone inhalers for asthma or COPD.

The global aerosol delivery devices market size was US$ 14.5 billion in 2021. The global aerosol delivery devices market is forecast to grow to US$ 21.1 billion by 2030 by growing at a compound annual ...

Beclometasone steroid inhalers help prevent asthma and COPD symptoms, but NHS guidance warns you must rinse your mouth or ...

The global respiratory device market witnessed substantial growth, reaching USD 15.8 billion in 2020 and is projected to reach USD 38.0 billion by 2027, with a notable CAGR of 13.5% during the ...

SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to properly use them. I'd ...